Vertaling van "issued for medicines " (Nederlands → Frans) :

The increased productivity is the result of concrete measures within the Registration department and has ensured that more MA are issued for medicines.
The increased productivity is the result of concrete measures within the Registration department and has ensured that more MA are issued for medicines.

Herbal medicinal products In line with the provisions of the royal decree of 14 December 2006, three procedures are used for the issue of the MA or registration for herbal medicinal products: the full procedure, the “Well Established Use” procedure and a third specific procedure for traditional herbal medicines as stipulated in article 43 of the royal decree.
Herbal medicinal products In line with the provisions of the royal decree of 14 December 2006, three procedures are used for the issue of the MA or registration for herbal medicinal products: the full procedure, the “Well Established Use” procedure and a third specific procedure for traditional herbal medicines as stipulated in article 43 of the royal decree.

In order to regulate the quality and relevance of messages to the public, a prior licence is required for radio and TV information campaigns about human health and illness which refer directly or indirectly to medicines. This licence is normally issued by the Minister responsible following advice from the Commission for the supervision of advertising for medicines for human use.
In order to regulate the quality and relevance of messages to the public, a prior licence is required for radio and TV information campaigns about human health and illness which refer directly or indirectly to medicines. This licence is normally issued by the Minister responsible following advice from the Commission for the supervision of advertising for medicines for human use.

There are two procedures for commercialising homoeopathic medicines on the Belgian market: the simplified registration procedure and the “full” procedure, leading to the issue of a MA.
There are two procedures for commercialising homoeopathic medicines on the Belgian market: the simplified registration procedure and the “full” procedure, leading to the issue of a MA.

The official role of this commission is to issue advice to determine the status of products when there is any doubt or uncertainty about whether or not they are medicines.
The official role of this commission is to issue advice to determine the status of products when there is any doubt or uncertainty about whether or not they are medicines.

European Union regulatory approval is anticipated soon, after the Committee for Medicinal Products (CHMP) issued a positive opinion in May supporting approval in renal cell carcinoma following progression on VEGF-targeted therapy.
Dans l’Union européenne, l’autorisation est attendue sous peu dès lors que le Committee for Medicinal Products (CHMP) a émis un avis favorable soutenant l’homologation dans le carcinome des cellules rénales à la suite de la progression du traitement ciblé sur le VEGF.

In the US, the FDA issued a Complete Response letter in December 2009 for this medicine (under the brand name Zortress) for prevention of organ rejection in adult kidney transplant patients.
Aux Etats-Unis, la FDA a émis, en décembre 2009, une «Complete Response letter» pour ce médicament (sous la marque Zortress) pour la prévention du rejet d'organe chez les transplantés adultes du rein.

The roles that pharmacists could play in this issue are: the ability to recognise risk factors such as a previous attempted suicide or the abusive use of medication, referring patients to health professionals when suspecting the early stages of a depression, and also to a certain extent following-up compliance and providing information on the side effects of the medicine.
Les rôles qui pourraient être attribués aux pharmaciens dans la problématique sont: savoir reconnaître les facteurs de risque comme une tentative de suicide antérieure ou l’abus de médicaments problématique, l’orientation vers des intervenants en cas de soupçon de début de dépression, et dans une certaine mesure également, le suivi de la compliance et l’information sur les effets secondaires des médicaments.